Section Arrow
CSBR.NASDAQ
- Champions Oncology
Quotes are at least 15-min delayed:2024/05/16 18:33 EDT
Last
 4.73
-0.0834 (-1.73%)
Day High 
4.87 
Prev. Close
4.8134 
1-M High
5.225 
Volume 
17.42K 
Bid
4.7
Ask
4.81
Day Low
4.65 
Open
4.86 
1-M Low
4.51 
Market Cap 
65.43M 
Currency USD 
P/E -- 
%Yield 1.45 
10-SMA 4.85 
20-SMA 4.92 
50-SMA 5.13 
52-W High 7.32 
52-W Low 4.51 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.72/0.05
Enterprise Value
72.82M
Balance Sheet
Book Value Per Share
-0.15
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
53.87M
Operating Revenue Per Share
3.88
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
SCPXScorpius Holdings0.1001+0.0224+28.83%-- 
DNAGinkgo Bioworks Holdings0.839-0.0001-0.01%-- 
NBYNovaBay Pharmaceuticals0.12+0.0155+14.83%-- 
JAGXJaguar Health0.2867+0.0316+12.39%-- 
NVAXNovavax14.4+1.5+11.63%-- 
Quotes are at least 15-min delayed:2024/05/16 18:33 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Champions Oncology Inc is a us-based company which is engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.